Case Studies, Pharmaceutical

Case Study – Unidose Nasal Spray Pump for Epilepsy

Seizure clusters, a potentially life-threatening symptom of epilepsy, can be treated by intramuscular injection with midazolam but only by a suitably trained responder. This case study describes a collaborative drug repurposing project with Aptar Pharma Services to develop a midazolam nasal spray as an easy to administer alternative, to address unmet medical need. The resulting product utilizes Aptar Pharma’s Unidose Liquid (UDS) device. Primeless and intuitive to use it can be administered by a wide range of potential carers, even to unresponsive patients. Aptar Pharma Services played an important role in optimizing the formulation for ‘nose-to-brain’ drug delivery, helping to establish a new first-in-class solution and valuable intellectual property.

Download Case Study - Unidose Nasal Spray Pump for Epilepsy
5 Jan 2023

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

5 Jan 2023

Case Study – Unidose Nasal Spray Pump for Epilepsy

Case Studies, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
8 Sep 2022

Case Study – Bidose Nasal Spray Pump for Depression

Case Studies, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
8 Sep 2022

Case Study – Unidose Nasal Spray Pump in Hypoglycemia

Case Studies, Pharmaceutical, Product Solutions, Device Innovations, Market Insights

Read More
8 Sep 2022

Case Study – Unidose Nasal Spray Pump for Opioid Overdose

Case Studies, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
1 2

Request Access

Close

Requesting access to Case Study – Unidose Nasal Spray Pump for Epilepsy.

  • This field is for validation purposes and should be left unchanged.
Back To Top